300267.SZ
尔康制药
SZSE · Healthcare · C 制造业 · CN
CNY 3.17
−1.55%Margins
Gross margin
27.0%
EBITDA margin
-17.7%
EBIT margin
-36.0%
Net margin
-37.3%
FCF margin
7.8%
-9.8%
Return on equity
-8.0%
Return on assets
-8.0%
Return on invested capital
0.22x
Asset turnover
CNY 251.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026